急性冠脈綜合征PCI術(shù)后伴抑郁患者左洛復(fù)干預(yù)的研究
本文選題:急性冠脈綜合征 切入點(diǎn):PCI 出處:《青島大學(xué)》2014年碩士論文
【摘要】:目的:觀察左洛復(fù)對急性冠脈綜合征(ACS)PCI術(shù)后合并抑郁患者抗抑郁治療的療效及對其低密度脂蛋白(LDL)、高敏C反應(yīng)蛋白(hsCRP)的影響。 方法:對150例確診為急性冠脈綜合征的患者行PCI術(shù)治療,術(shù)后從中篩選出伴有抑郁癥患者并通過漢密爾頓(HAMD)抑郁量表對其進(jìn)行評分。后將合并有抑郁的患者隨機(jī)分成兩組,分別給予心理治療(對照組)和左洛復(fù)治療(治療組)。2月后對比兩組患者的LDL、hsCRP水平,再次利用HAMD抑郁量表進(jìn)行評分,根據(jù)評分減分率判斷左洛復(fù)抗抑郁治療的療效。 結(jié)果: (1)2月后治療組LDL.hsCRP水平(分別為1.70±0.56mmol/L、0.27±0.02ng/ml)明顯低于對照組LDL、hsCRP水平(分別為2.13±0.62mmol/L、0.45±0.33ng/ml),差異具有統(tǒng)計(jì)學(xué)意義(P均0.05)。 (2)經(jīng)治療后,兩組患者的抑郁癥狀均得到了改善,與對照組相比,治療組抗抑郁治療的效果要明顯優(yōu)于對照組(治愈及顯效的例數(shù)明顯多于對照組),差異具統(tǒng)計(jì)學(xué)意義(P0.05)。 (3)左洛復(fù)引起的藥物不良反應(yīng)與對照組相比無明顯增加,兩組間差異無統(tǒng)計(jì)學(xué)意義(P0.1)。 結(jié)論: (1)對急性冠脈綜合征PCI術(shù)后合并有抑郁的患者給予左洛復(fù)治療是安全的。 (2)對抑郁的治療,藥物可能比單純給予心理治療更有效。 (3)左洛復(fù)通過對抑郁的治療,間接降低冠心病危險(xiǎn)因子LDL、hsCRP的水平,對患者預(yù)后可能有重要意義。
[Abstract]:Aim: to observe the effect of zolofur on antidepressant treatment of patients with depression after acute coronary syndrome (ACSC) PCI and its effect on low density lipoprotein (LDL) and Gao Min C-reactive protein (Gao Min C reactive protein hsCRP).Methods: 150 patients with acute coronary syndrome were treated with PCI.The patients with depression were randomly divided into two groups. They were treated with psychotherapy (control group) and Zolofu (treatment group). Two months after treatment, the patients in both groups were compared with the level of HAMD hs CRP, and the scores were evaluated by HAMD depression scale.The efficacy of levofloxacin in antidepressant treatment was evaluated according to the score reduction rate.Results:After 2 months, the level of LDL.hsCRP in the treatment group (1.70 鹵0.56 mmol / L 0.27 鹵0.02 ng / ml, respectively) was significantly lower than that in the control group (2.13 鹵0.62 mmol / L 0.45 鹵0.33 ng / ml, P < 0.05).2) after treatment, the depressive symptoms of the two groups were improved. Compared with the control group, the effect of antidepressant treatment in the treatment group was obviously better than that in the control group (the number of cured and effective cases was obviously more than that in the control group, the difference was statistically significant (P 0.05).3) there was no significant increase in adverse drug reactions induced by zolofur compared with the control group, and there was no significant difference between the two groups (P 0.1).Conclusion:It is safe to treat acute coronary syndrome patients with depression after PCI.Drugs may be more effective than psychotherapy alone in the treatment of depression.Through the treatment of depression, Zolofu can indirectly reduce the level of LDL- hsCRP, which may play an important role in the prognosis of patients with coronary heart disease.
【學(xué)位授予單位】:青島大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R541.4;R749.4
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 劉梅顏;;雙心醫(yī)學(xué)的發(fā)展與爭議[J];中國循環(huán)雜志;2013年01期
2 葉慶紅;陳志斌;唐鍇;潘宏彬;劉樹嬌;;舒肝解郁膠囊治療老年冠心病介入手術(shù)前后焦慮、抑郁39例療效觀察[J];中醫(yī)藥導(dǎo)報(bào);2012年03期
3 龐可可;張珍;白云飛;王顯;;抗抑郁藥對老年冠心病合并抑郁癥患者介入手術(shù)后的療效分析[J];中國醫(yī)藥指南;2012年07期
4 張潤峰;胡大一;高文根;邢燕;魏毅東;;雙心診療模式對急性心肌梗死患者預(yù)后的影響[J];中國當(dāng)代醫(yī)藥;2011年25期
5 李建杰;平玉娟;鄭軼;;中醫(yī)藥在PCI術(shù)后抑郁癥治療中的臨床運(yùn)用[J];光明中醫(yī);2011年07期
6 汪強(qiáng);宋建平;儲珍玉;戴學(xué)英;;急性冠狀動脈綜合征患者抑郁焦慮狀態(tài)分析[J];中華臨床醫(yī)師雜志(電子版);2011年04期
7 韓立憲;吳莉娜;張紅娟;曹緒芬;顏利求;韓佳;劉志先;楊啟成;;冠心病患者經(jīng)皮冠狀動脈介入術(shù)后焦慮及抑郁情緒心理干預(yù)的研究[J];中國介入心臟病學(xué)雜志;2009年02期
8 岳桂珍,張蔭川;抑郁情緒對穩(wěn)定型心絞痛患者心肌缺血頻度和程度的影響[J];中國臨床康復(fù);2004年18期
9 曹晶;抑郁癥與冠心病[J];中國心血管雜志;2004年02期
10 唐勝修,徐祖豪,唐萍,李鳳萍;針刺治療抑郁性神經(jīng)癥的臨床研究[J];中國針灸;2003年10期
,本文編號:1724397
本文鏈接:http://sikaile.net/yixuelunwen/jsb/1724397.html